BGC > Product Search > Mirabegron impurity 002 | 81259-56-5

Molecular Formula: C10H11NO2
Molecular Weight: 177.2

Description :
An impurity of Mirabegron. Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity.

• Molecular Weight :177.20
• Purity :95%

Molecular Formula :
C10H11NO2
Canonical SMILES :
CCOC1=C(C=C(C=C1)C#N)OC
InChI :
InChI=1S/C10H11NO2/c1-3-13-9-5-4-8(7-11)6-10(9)12-2/h4-6H,3H2,1-2H3
InChIKey :
RSQBGXAHUGQQNQ-UHFFFAOYSA-N
Solubility :
Soluble in DMSO
Appearance :
Solid
Storage : -20°C
Synonyms :
4-ethoxy-3-methoxybenzonitrile; 81259-56-5; SCHEMBL6944897; MFCD02256107; AKOS000198357; 4-ETHOXY-3-METHOXY-BENZONITRILE; CS-0319395; Z54794538

More details are to be found here